#TeachMS: virtual MS Academy meetings


If you are a Healthcare Professional (HCP) and are interested in getting up to speed on some advanced topics around the management of MS please take a look at the programme below. We converted our November meeting to be virtual, which has opened some spaces for more people to attend.

Please register via the following link: Advanced MS Academy 4-6 November 2020 Online.

If you have any queries please don’t hesitate to contact me. In addition, if you have any topics you think we should cover please let me know.

CoI: multiple

About the author

Prof G

Professor of Neurology, Barts & The London. MS & Preventive Neurology thinker, blogger, runner, vegetable gardener, husband, father, cook and wine & food lover.


  • HSCT – are we ready to offer it first-line?
    Dr Ben Turner, Consultant Neurologist, Barts Health NHS Trust

    very exciting ! lets hope so !

    • I hope by asking the question, “HSCT – are we ready to offer it first-line?”, we are pushing the bubble and challenging HCPs to think about treating MS aggressively as early as possible.

    • Yes, but only via a firewall for members of the MS Academy. I will speak to the company and see if they will make them available for all to view.

  • I’ve got a few questions :

    Why was the research into remylination and citicoline stopped (when results were promising; oh but it was reclassified as a supplement)

    Why isn’t Savitex available on prescription;
    (despite what NICE said) for pwMS to help ease symptoms and improve quality of life?

    When is any effort going to be put into finding a cure?

    • Citicoline was always available as a supplement. It has modest evidence as a nootropic and is generally sold as such. Ironically I used it for a while about 10 years ago, maybe I should try again. Same for ALCAR BTW.

      This might be an interesting topic for investigation – maybe nootropics could help some of the cognitive issues. Sadly there seems to very little in the line of dependable studies, no doubt partially because they cannot be patented.

  • Thank you for responding
    Mouse doctor talked about citicoline 6 years ago in this blog when it was a pharmaceutical and promising remylination therapy – then it got reclassified as a nutriceutical and all talk stopped and that hope was abandoned ? – https://multiple-sclerosis-research.org/2014/12/remyelination-with-citicoline/

    “After cuprizone-induced demyelination, CDP-choline effectively enhanced myelin regeneration and reversed motor coordination deficits”

    As for savitex it comes in at at a cost of £400 – which is far cheaper than a dose of DMD ?

    We don’t hear anything about cures , we hear about DMDS destroying quality of life and ultimately failing

By Prof G



Recent Posts

Recent Comments